Combining data tokenization and real-world patient insights to bridge the gap for a more diverse and complete dataset
Clinical expert, David Barrett shares insights on how we linked real-world data with personal characteristics, such as race, ethnicity, and social determinants of health, to gain a more complete view of patients. This research aims to educate drug developers on ways to improve patient representation in clinical trials, address shortcomings in linking real-world data (RWD), and enhance the understanding of patient journeys and outcomes.
Related Insights
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Blog
Studying rare cancer patient populations using integrated genomic and real-world data
Aug 30, 2023
Blog
Transforming evidence generation: How predictive AI can optimize clinical development
Sep 3, 2024
Article
3 ways to incorporate DE&I in your communications strategy
Sep 29, 2021
Video
Ensuring Diversity & Inclusion for Clinical Trials
Jul 8, 2022
Blog
Parexel names first Patient Ambassador
Jun 17, 2022
Blog
Maintaining Data Integrity for Quality and Compliance – Essential Despite Pandemic Disruptions
May 16, 2022
Article
New FDA Guidance Addresses the Need for Data-Generation Strategies Across the Drug Development Lifecycle
May 10, 2022
Blog
Patient Advocacy Groups: A vital partner for sponsors that understand how to engage with patients
May 3, 2022
Blog
Patients as Partners 2022: Moving from Insights to Action
May 3, 2022
Blog
Toward more inclusive studies: Reaching and retaining patients from underrepresented communities
Apr 25, 2022
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Related Insights
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Blog
Studying rare cancer patient populations using integrated genomic and real-world data
Aug 30, 2023
Blog
Transforming evidence generation: How predictive AI can optimize clinical development
Sep 3, 2024
Article
3 ways to incorporate DE&I in your communications strategy
Sep 29, 2021
Video
Ensuring Diversity & Inclusion for Clinical Trials
Jul 8, 2022
Blog
Parexel names first Patient Ambassador
Jun 17, 2022
Blog
Maintaining Data Integrity for Quality and Compliance – Essential Despite Pandemic Disruptions
May 16, 2022
Article
New FDA Guidance Addresses the Need for Data-Generation Strategies Across the Drug Development Lifecycle
May 10, 2022
Blog
Patient Advocacy Groups: A vital partner for sponsors that understand how to engage with patients
May 3, 2022
Blog
Patients as Partners 2022: Moving from Insights to Action
May 3, 2022
Blog
Toward more inclusive studies: Reaching and retaining patients from underrepresented communities
Apr 25, 2022
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021